MKMasaki Kobayashi
Masaki Kobayashi
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Masaki Kobayashi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Akane Suzuki
Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan
19 shared publications - Akane Tomizawa
Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan
19 shared publications - Atsushi Hirao
Division of Molecular Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
19 shared publications - Eiichi Hinoi
Department of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University, Gifu, Japan
19 shared publications - Jiajun Lyu
Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan
19 shared publications - Kazuya Fukasawa
Lab. Pharmacol., Dept. Bioactive Molecules, Gifu Pharmaceutical Univ
19 shared publications
Latest Publications
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table ST1 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table ST1 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S6 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S5 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table ST1 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table ST1 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S7 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells